Articles from Positron Corporation

Buffalo, NY, Nov. 17, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced that it has become a reporting company with the U.S Securities and Exchange Commission (SEC).  The Company filed a Form 10 registration statement with the SEC containing all required financial statements and disclosures and is now subject to the reporting requirements of the Securities Exchange Act of 1934, as amended. The Company will now be filing its quarterly and annual reports with the SEC, along with current reports to provide updates on material events.

Buffalo, NY, Oct. 02, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leading molecular imaging technology company specializing in PET and PET-CT imaging systems and clinical services is pleased to announce a partnership with MedAxiom, the cardiovascular community’s premier source for organizational performance solutions. 

Buffalo, NY, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced that it has won the Innovation Award in the PET-CT Imaging category in the 2025 Medical Device Network Excellence Awards for making a substantial impact on the evolution of PET-CT imaging technology. The company’s latest PET-CT systems have introduced significant advancements in affordability, workflow, and clinical application.

North Tonawanda, NY, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Positron Corporation (“Positron” or the “Company”) (OTC: POSC), a leader in molecular imaging technology and services, today announced that the Company had established a new corporate headquarters in the Buffalo-Niagara Falls region, and that its Board of Directors has approved the redomiciling of the Company from Texas to Delaware.